Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A, Hemophilia B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01830712
What this trial is testing

A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 15
Not applicableStudy completedNCT00936845
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 22
Not applicableUnknownNCT05889754
What this trial is testing

Reliability and Validity of the Turkish Version of the PedHAL

Who this might be right for
HemophiliaHemophilia A, SevereHemophilia B
Hasan Kalyoncu University 50
Not applicableStudy completedNCT03507582
What this trial is testing

Virtual Reality for Hemophilia

Who this might be right for
Hemophilia AHemophilia B
Nationwide Children's Hospital 25
Not applicableEnrolling By InvitationNCT03745924
What this trial is testing

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

Who this might be right for
Haemophilia B
Novo Nordisk A/S 60
Not applicableStudy completedNCT07425327
What this trial is testing

Validity and Reliability of the Two-minute Step Test in Hemophilia

Who this might be right for
HemophiliaStepReliability and Validity+1 more
Hasan Kalyoncu University 31
Not applicableStudy completedNCT04590950
What this trial is testing

Dosage and PD Study of Eftrenonacog-alfa

Who this might be right for
Severe Haemophilia B
Assistance Publique - Hôpitaux de Paris 15
Not applicableNot Yet RecruitingNCT07421154
What this trial is testing

Study of a Smart Sharps Disposal Device in Patients With Hemophilia

Who this might be right for
Hemophilia A and B
University of Pennsylvania 23
Very early researchUnknownNCT05152732
What this trial is testing

Safety and Tolerability of VGB-R04 in Patients With Haemophilia B

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 3
Testing effectiveness (Phase 2)Ended earlyNCT04394286
What this trial is testing

SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects

Who this might be right for
Hemophilia B
Baxalta now part of Shire 2
Not applicableStudy completedNCT00244114
What this trial is testing

Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT03363321
What this trial is testing

PF-06741086 Long-term Treatment in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 20
Post-approval studies (Phase 4)Study completedNCT00571584
What this trial is testing

High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 24
Large-scale testing (Phase 3)Study completedNCT03855280
What this trial is testing

Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B

Who this might be right for
Hemophilia B
Medexus Pharma, Inc. 21
Post-approval studies (Phase 4)Ended earlyNCT05856266
What this trial is testing

An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa

Who this might be right for
Hemophilia AHemophilia B
Swedish Orphan Biovitrum 10
Testing effectiveness (Phase 2)Study completedNCT02396342
What this trial is testing

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 10
Very early researchStudy completedNCT04789954
What this trial is testing

Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
AryoGen Pharmed Co. 14
Large-scale testing (Phase 3)Study completedNCT00543439
What this trial is testing

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Who this might be right for
Hemophilia A
Pfizer 66
Large-scale testing (Phase 3)Study completedNCT01286779
What this trial is testing

BAX 326 (rFIX) Continuation Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 117
Not applicableEnded earlyNCT02392156
What this trial is testing

Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes

Who this might be right for
Hemophilia AHemophilia B
Bioverativ Therapeutics Inc. 3
Next Page